Cargando…
A randomized controlled trial investigation of a non-stimulant in attention deficit hyperactivity disorder (ACTION): Rationale and design
BACKGROUND: The ACTION study (Attention deficit hyperactivity disorder Controlled Trial Investigation Of a Non-stimulant) is a multi-center, double-blind, randomized cross-over trial of the non-stimulant medication, Atomoxetine, in children and adolescents with attention deficit hyperactivity disord...
Autores principales: | Tsang, Tracey W, Kohn, Michael R, Hermens, Daniel F, Clarke, Simon D, Clark, C Richard, Efron, Daryl, Cranswick, Noel, Lamb, Chris, Williams, Leanne M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068100/ https://www.ncbi.nlm.nih.gov/pubmed/21396130 http://dx.doi.org/10.1186/1745-6215-12-77 |
Ejemplares similares
-
Efficacy and Safety of Atomoxetine in the Treatment of Children and Adolescents with Attention Deficit Hyperactivity Disorder
por: Kohn, Michael R., et al.
Publicado: (2012) -
The Australian evidence-based clinical practice guideline for attention deficit hyperactivity disorder
por: May, Tamara, et al.
Publicado: (2023) -
Study protocol: the sleeping sound with attention-deficit/hyperactivity disorder project
por: Sciberras, Emma, et al.
Publicado: (2010) -
Longitudinal maturation of resting state networks: Relevance to sustained attention and attention deficit/hyperactivity disorder
por: Thomson, Phoebe, et al.
Publicado: (2022) -
Regional brain network organization distinguishes the combined and inattentive subtypes of Attention Deficit Hyperactivity Disorder
por: Saad, Jacqueline F., et al.
Publicado: (2017)